Astec LifeSciences (ASTEC) | Stock Overview & Key Data
Astec LifeSciences Performance Comparison
Stock Range
Today's Range
Low: ₹790.00
High: ₹815.90
on October 3, 2025
52 Week Range
Low: ₹634.60
High: ₹1,263.85
on May 9, 2025
on January 7, 2025
All-Time High: ₹2,288.80 on November 14, 2022
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR17.9B
EPS
-64.79
P/E Ratio (TTM)
399.52
Forward P/E
19.88
P/B Ratio
6.71
PEG Ratio
-22.88
Div. Yield
N/A
ROE
-57.34%
Beta
0.031
Debt to Equity
235.96
Financial Highlights
Profitability
Gross Margin
29.86%
Operating Margin
-24.68%
Profit Margin
-31.78%
Returns and Earnings
Return on Assets (TTM)
-15.29%
Return on Equity (TTM)
-57.34%
EBITDA
INR-321.0M
Net Income (TTM)
INR-1.3B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR203.94
Quarterly Revenue Growth (YoY)
31.30%
Quarterly Earnings Growth (YoY)
31.29%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Astec LifeSciences ASTEC | 17.94B Small-cap | -2.86% | -6.77% | -15.38% | 9.70% | -19.12% | -29.92% | -57.43% | -29.23% |
| Coromandel COROMANDEL | 682.36B Large-cap | 5.25% | -2.26% | 3.04% | 11.70% | 19.33% | 42.08% | 130.74% | 218.15% |
| UPL UPLPP | 620.31B Large-cap | 0.00% | 0.00% | 16.46% | 20.65% | 129.00% | 104.96% | 104.96% | 104.96% |
| National Fertilizers NFL | 46.65B Small-cap | 3.61% | -5.06% | -4.69% | 15.13% | -19.62% | -20.39% | 91.24% | 192.73% |
| NACL Industries NACLIND | 42.69B Small-cap | -7.61% | -24.74% | -11.51% | 81.23% | 202.19% | 273.72% | 168.91% | 431.13% |
| Bharat Rasayan BHARATRAS | 42.22B Small-cap | 0.78% | -1.26% | -11.98% | -7.09% | -1.03% | -11.30% | -9.36% | 13.03% |
Ownership & Short Interest
Insider Ownership
84.14%
Institutional Ownership
6.93%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
13K
Average 90-Day Volume
24K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ASTEC's 52-week high and low?
- In the last 52 weeks, Astec LifeSciences reached a high of ₹1,263.85 (on January 7, 2025) and a low of ₹634.60 (on May 9, 2025).
- What is the market cap and P/E ratio for ASTEC?
- Curious about Astec LifeSciences's size and valuation? Its market capitalization stands at 17.94B. When it comes to valuation, the P/E ratio (trailing twelve months) is 399.52, and the forward P/E (looking ahead) is 19.88.
- Does ASTEC pay dividends? If so, what's the yield?
- As for dividends, Astec LifeSciences isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Astec LifeSciences's main competitors or similar companies to consider before investing?
When looking at Astec LifeSciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Coromandel
COROMANDEL682.36B Basic Materials Agricultural Inputs 42.08% 130.74% UPL
UPLPP620.31B Basic Materials Agricultural Inputs 104.96% 104.96% National Fertilizers
NFL46.65B Basic Materials Agricultural Inputs -20.39% 91.24% NACL Industries
NACLIND42.69B Basic Materials Agricultural Inputs 273.72% 168.91% Bharat Rasayan
BHARATRAS42.22B Basic Materials Agricultural Inputs -11.30% -9.36% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Astec LifeSciences Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Astec LifeSciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -57.34%, the Debt to Equity ratio from the most recent quarter is 235.96, and its Gross Profit Margin stands at 29.86%.
- What is the recent revenue and earnings growth for ASTEC?
- Looking at Astec LifeSciences's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 31.30%, and quarterly earnings saw a YoY growth of 31.29%.
- How much of ASTEC stock is held by insiders and institutions?
- Wondering who owns Astec LifeSciences stock? Company insiders (like executives and directors) hold about 84.14% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 6.93%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.